New Drugs FDA Approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) 4 years ago
Healthcare News Signs You Are Suffering From Chronic Stress Due To Pandemic, Current Social Unrest 4 years ago
Pharma Industry News Hydroxychloroquine fails trial as preventative measure against COVID-19 4 years ago
Pharma Industry News Biogen launches digital self-help tool to support mental health in MS 4 years ago